In pre-chemotherapy samples, the proportions of tumor cells, STAR + cells, and T lymphocytes were higher in the sensitive group, while CAFs and macrophages were more abundant in the resistant group (Figure 3D). This evidence concerns the gene STAR and neoplasm.